Finch Therapeutics Group, Inc. 3 SEC Filings

Filed On	Filing
16 May 2023	Form 3: Blischak Matthew P., Chief Executive Officer No securities owned
16 May 2023	Form 3: Thibault Lance E, Chief Financial Officer No securities owned
05 Oct 2021	Form 3: Hamood Samuel A, Director No securities owned
10 Sep 2021	Form 3: Blaustein Marc, Chief Operating Officer No securities owned
27 Apr 2021	Form 3: Graf Susan E, Director No securities owned
18 Mar 2021	Form 3: Vittiglio Joseph, General Counsel and Secretary
18 Mar 2021	Form 3: Viney Joanne L., Director
18 Mar 2021	Form 3: Lange Christian H., Director No securities owned
18 Mar 2021	Form 3: Smith Mark Burnham, Director Holds 1,903,033 shares of Common Stock
18 Mar 2021	Form 3: Smisek Jeffery A, Director
18 Mar 2021	Form 3: Perry Gregory D, Chief Financial Officer
18 Mar 2021	Form 3: Kassam Zain, Chief Medical Officer Holds 1,330,351 shares of Common Stock
18 Mar 2021	Form 3: Crestovo Investor Llc, Director and 1 other
18 Mar 2021	Form 3: Haft Nicholas, Director
18 Mar 2021	Form 3: Ferrante Domenic J, Director

Comments